|
KMID : 0043320120350071241
|
|
Archives of Pharmacal Research
2012 Volume.35 No. 7 p.1241 ~ p.1250
|
|
|
Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats
|
|
Qin Renan
Zhang Jianyu
Li Chuyuan
Zhang Xiaoqi
Xiong Aihua
Huang Feng
Yin Zhen
Li Kongyan
Qin Wenyu
Chen Mingzhen
Zhang Shubing
Liang Lingyi
Zhang Huiye
Nie Hong
Ye Wencai
|
|
|
Abstract
|
|
|
|
In the present study, the protective effects of gypenosides from Gynostemma pentaphyllum on fatty liver disease (FLD) were examined in rats treated with high fat and cholesterol diet and alcohol. Male SD rats were divided into seven groups: control, model, lovastatin, silymarin, gypenosides high-, medium- and low-treatment groups. The latter 6 groups were fed high-fat and cholesterol diet and administered alcohol intragastricly once a day. Body weight was measured every week for 10 weeks, and the hepatic index was measured after 10 weeks. Compared with model group, levels of serum triglyceride (TG), total cholesterol (TC), free fatty acid (FFA), and low density lipoprotein cholesterol (LDL-C) level, malondialdehyde (MDA), serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity, and hepatocyte apoptosis were significantly decreased in gypenosides groups; while serum high density lipoprotein cholesterol (HDL-C), superoxide dismutase (SOD) activity in both serum and hepatic tissue and mRNA and protein level of peroxisome proliferator-activated receptor α (PPAR-α) were significantly increased. Moreover, hepatic steatosis and mitochondrial damage were improved. These results suggested that gypenosides could prevent liver fatty degeneration in fatty liver disease through modulating lipid metabolism, ameliorating liver dysfunction and reducing oxidative stress.
|
|
|
KEYWORD
|
|
|
Fatty liver disease, Animal model, Gypenosides, Lipid metabolism, PPAR-α
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|